Masaaki Yasui
Wakayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Metabolic changes in the plasma of mild Alzheimer's disease patients treated with Hachimijiogan.
Journal: Frontiers in pharmacology
Published: April 10, 2023
Diagnostic utility of susceptibility-weighted imaging in amyotrophic lateral sclerosis.
Journal: Journal of the neurological sciences
Published: August 05, 2022
An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease.
Journal: Frontiers in pharmacology
Published: July 12, 2022
Validation of the Japanese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).
Journal: Parkinson's disease
Published: September 07, 2021
Preventive effect of a heparinoid-containing product on the application site reaction of the rotigotine transdermal patch in Parkinson's disease: A pilot randomized clinical trial (the SkinHeRo study).
Journal: Clinical parkinsonism & related disorders
Published: June 18, 2021
Increased large-scale inter-network connectivity in relation to impulsivity in Parkinson's disease.
Journal: Scientific reports
Published: January 31, 2020
A case of anti-N-methyl-d-aspartate receptor encephalitis with multiple sclerosis-like demyelinated lesions.
Journal: Multiple sclerosis and related disorders
Published: May 21, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026